AT352129B - Verfahren zur herstellung des neuen 2,6- dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)- 1,4-dihydropyridin-5-carbonsaeureisobutylesters - Google Patents

Verfahren zur herstellung des neuen 2,6- dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)- 1,4-dihydropyridin-5-carbonsaeureisobutylesters

Info

Publication number
AT352129B
AT352129B AT814276A AT814276A AT352129B AT 352129 B AT352129 B AT 352129B AT 814276 A AT814276 A AT 814276A AT 814276 A AT814276 A AT 814276A AT 352129 B AT352129 B AT 352129B
Authority
AT
Austria
Prior art keywords
dihydropyridin
methoxycarbonyl
nitrophenyl
dimethyl
producing
Prior art date
Application number
AT814276A
Other languages
German (de)
English (en)
Other versions
ATA814276A (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ATA814276A publication Critical patent/ATA814276A/de
Application granted granted Critical
Publication of AT352129B publication Critical patent/AT352129B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT814276A 1975-11-05 1976-11-03 Verfahren zur herstellung des neuen 2,6- dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)- 1,4-dihydropyridin-5-carbonsaeureisobutylesters AT352129B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2549568A DE2549568C3 (de) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
ATA814276A ATA814276A (de) 1979-02-15
AT352129B true AT352129B (de) 1979-09-10

Family

ID=5960951

Family Applications (1)

Application Number Title Priority Date Filing Date
AT814276A AT352129B (de) 1975-11-05 1976-11-03 Verfahren zur herstellung des neuen 2,6- dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)- 1,4-dihydropyridin-5-carbonsaeureisobutylesters

Country Status (27)

Country Link
JP (1) JPS5259161A (ja)
AT (1) AT352129B (ja)
AU (1) AU498964B2 (ja)
BE (1) BE847968A (ja)
BG (6) BG25078A3 (ja)
CA (1) CA1085406A (ja)
CH (2) CH623038A5 (ja)
CS (1) CS200499B2 (ja)
DE (1) DE2549568C3 (ja)
DK (1) DK146762C (ja)
ES (2) ES452986A1 (ja)
FI (1) FI60704C (ja)
FR (1) FR2330395A1 (ja)
GB (1) GB1516793A (ja)
GR (1) GR61241B (ja)
HK (1) HK12681A (ja)
IE (1) IE43984B1 (ja)
IL (1) IL50817A (ja)
LU (2) LU88275I2 (ja)
NL (2) NL175915C (ja)
NO (1) NO145574C (ja)
NZ (1) NZ182502A (ja)
PL (2) PL106084B1 (ja)
PT (1) PT65797B (ja)
RO (1) RO70295A (ja)
SE (1) SE423542B (ja)
ZA (1) ZA766622B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS5982192U (ja) * 1982-11-27 1984-06-02 エムケ−精工株式会社
DE3312216A1 (de) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE2549568A1 (de) 1977-05-18
DK146762C (da) 1984-06-12
CH623038A5 (en) 1981-05-15
NL930035I2 (nl) 1993-10-01
SE423542B (sv) 1982-05-10
DE2549568B2 (de) 1980-08-21
BG25078A3 (en) 1978-07-12
BG24805A3 (en) 1978-05-12
AU498964B2 (en) 1979-03-29
ES452986A1 (es) 1977-12-16
FI60704B (fi) 1981-11-30
GB1516793A (en) 1978-07-05
SE7612308L (sv) 1977-05-06
BG25079A3 (en) 1978-07-12
LU76133A1 (ja) 1977-06-02
CH622779A5 (en) 1981-04-30
JPS5259161A (en) 1977-05-16
BG24804A3 (en) 1978-05-12
CS200499B2 (en) 1980-09-15
PT65797B (de) 1978-05-12
BG24803A3 (en) 1978-05-12
PL105940B1 (pl) 1979-11-30
AU1935876A (en) 1978-05-11
NO145574C (no) 1982-04-21
NZ182502A (en) 1978-07-28
DK146762B (da) 1983-12-27
BG24668A3 (en) 1978-04-12
IE43984B1 (en) 1981-07-15
LU88275I2 (ja) 1994-02-03
CA1085406A (en) 1980-09-09
GR61241B (en) 1978-10-12
NL930035I1 (nl) 1993-08-02
DK498476A (da) 1977-05-06
NL7612198A (nl) 1977-05-09
ZA766622B (en) 1977-10-26
PL106084B1 (pl) 1979-11-30
FR2330395B1 (ja) 1978-12-22
PT65797A (de) 1976-12-01
NO763608L (ja) 1977-05-06
DE2549568C3 (de) 1981-10-29
ES463166A1 (es) 1978-07-16
NO145574B (no) 1982-01-11
HK12681A (en) 1981-04-10
BE847968A (fr) 1977-05-04
IL50817A0 (en) 1977-01-31
ATA814276A (de) 1979-02-15
IE43984L (en) 1977-05-05
NL175915C (nl) 1985-01-16
IL50817A (en) 1979-07-25
FR2330395A1 (fr) 1977-06-03
JPS5647185B2 (ja) 1981-11-07
RO70295A (ro) 1981-08-17
FI60704C (fi) 1982-03-10
FI763160A (ja) 1977-05-06

Similar Documents

Publication Publication Date Title
AT347582B (de) Verfahren zur herstellung des neuen 4'- deoxydaunomycins
AT360663B (de) Verfahren zur herstellung von neuen 6,7- -benzomorphanen
AT358029B (de) Verfahren zur herstellung von neuen thiazolinyl- oder 5,6-dihydrothiazinylbenzimid- azolcarbonsaeureestern
AT356671B (de) Verfahren zur herstellung von neuen n,n'-thio- -di-carbamaten
AT343616B (de) Verfahren zur herstellung des neuen 1,2,2,2-tetrafluorathyl - fluormethylathers
AT354626B (de) Verfahren zur herstellung von neuen 7-acyl- amino-8-oxo-3-oxa-1-azabicyclo/4.2.0/octan-2- carbonsaeure-derivaten
AT354434B (de) Verfahren zur herstellung von neuen 1,4- diphenyl-3-pyrazolin-5-onen
AT352129B (de) Verfahren zur herstellung des neuen 2,6- dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)- 1,4-dihydropyridin-5-carbonsaeureisobutylesters
AT358006B (de) Verfahren zur herstellung der neuen 4-iso- hexyl-1-methylcyclohexancarbonsaeure
AT351689B (de) Verfahren zur herstellung des neuen l- pyroglutamyl-l-prolinamids
ATA271877A (de) Verfahren zur herstellung des neuen n-n-butyl-n-cetyl-6-amino-1-hexanols
ATA739376A (de) Verfahren zur herstellung des neuen o,o-diathyl-o- (n-methoxy-2-nitrobenzimidoyl)-thionophosphorsaureesters
ATA438776A (de) Verfahren zur herstellung von neuen 16-athern von fusidinsaurederivaten
AT358575B (de) Verfahren zur herstellung von neuen 2- carbalkoxyamino-5(6)-phenyl-sulfonyloxy- -benzimidazolen
AT354466B (de) Verfahren zur herstellung der neuen n,n- dimethylaminomethan-diphosphonsaeure
AT351014B (de) Verfahren zur herstellung des neuen 2-methyl- 4-trifluormethylanilins
AT345479B (de) Verfahren zur herstellung des neuen 3beta- (4'-oxo-alfa-l-rhamnosyl) -14beta-hydroxy-bufa-4,20,22-trienolids
AT343636B (de) Verfahren zur herstellung der neuen 2-(2'-n,n-diathylaminoathoxy)-3- propionylbenzoesaure
AT352719B (de) Verfahren zur herstellung des neuen 2,6,6- trimethyl-2-cyanmethyl-tetrahydropyrans
AT357562B (de) Verfahren zur herstellung des neuen n-methoxy- carbonyl-n'-trifluormethansulfonylhydrazins
AT347051B (de) Verfahren zur herstellung des neuen 2,4,5- trimethylthien(3,2-f)morphans
ATA68278A (de) Verfahren zur herstellung des neuen 4'-deoxyadriamycins
ATA160279A (de) Verfahren zur herstellung von neuen unsymetrischen n,n'-thio-di-carbamaten
ATA491279A (de) Verfahren zur herstellung von neuen 2,9-alpha-
AT362877B (de) Verfahren zur herstellung von neuen 3,7disubstituierten 3-cephem-4-carbonsaeureverbindungen

Legal Events

Date Code Title Description
ELA Expired due to lapse of time